UB
ITCI
UMB Bank’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,622
| Closed | -$610K | – | 2198 |
|
|
2025
Q1 | $610K | Buy |
4,622
+2
| +0% | +$264 | 0.01% | 385 |
|
|
2024
Q4 | $386K | Hold |
4,620
| – | – | 0.01% | 441 |
|
|
2024
Q3 | $338K | Hold |
4,620
| – | – | 0.01% | 473 |
|
|
2024
Q2 | $316K | Hold |
4,620
| – | – | 0.01% | 470 |
|
|
2024
Q1 | $320K | Hold |
4,620
| – | – | 0.01% | 480 |
|
|
2023
Q4 | $331K | Sell |
4,620
-36
| -0.8% | -$2.58K | ﹤0.01% | 478 |
|
|
2023
Q3 | $243K | Hold |
4,656
| – | – | ﹤0.01% | 523 |
|
|
2023
Q2 | $295K | Hold |
4,656
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $252K | Hold |
4,656
| – | – | ﹤0.01% | 527 |
|
|
2022
Q4 | $246K | Hold |
4,656
| – | – | ﹤0.01% | 537 |
|
|
2022
Q3 | $217K | Hold |
4,656
| – | – | ﹤0.01% | 585 |
|
|
2022
Q2 | $266K | Sell |
4,656
-400
| -8% | -$22.9K | ﹤0.01% | 569 |
|
|
2022
Q1 | $309K | Buy |
5,056
+400
| +9% | +$24.4K | ﹤0.01% | 564 |
|
|
2021
Q4 | $244K | Buy |
+4,656
| New | +$244K | ﹤0.01% | 628 |
|